156 related articles for article (PubMed ID: 31987854)
1. Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice.
Yamagata R; Nemoto W; Nakagawasai O; Takahashi K; Tan-No K
Biochem Pharmacol; 2020 Apr; 174():113825. PubMed ID: 31987854
[TBL] [Abstract][Full Text] [Related]
2. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
Ogata Y; Nemoto W; Yamagata R; Nakagawasai O; Shimoyama S; Furukawa T; Ueno S; Tan-No K
Eur J Pain; 2019 Apr; 23(4):739-749. PubMed ID: 30421564
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Spinal Angiotensin II System in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice.
Ogata Y; Nemoto W; Nakagawasai O; Yamagata R; Tadano T; Tan-No K
Mol Pharmacol; 2016 Sep; 90(3):205-13. PubMed ID: 27401876
[TBL] [Abstract][Full Text] [Related]
4. Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice.
Nemoto W; Yamagata R; Nakagawasai O; Nakagawa K; Hung WY; Fujita M; Tadano T; Tan-No K
Eur J Pharmacol; 2020 Apr; 872():172950. PubMed ID: 31987711
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral and Molecular Pharmacological Study of the Role of Angiotensin II in Spinal Pain Transmission].
Nemoto W
Yakugaku Zasshi; 2018; 138(10):1235-1240. PubMed ID: 30270265
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of angiotensin (1-7) on angiotensin III-induced nociceptive behaviour in mice.
Nemoto W; Yamagata R; Ogata Y; Nakagawasai O; Tadano T; Tan-No K
Neuropeptides; 2017 Oct; 65():71-76. PubMed ID: 28559062
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis prevents pancreatic acinar cell inflammatory response via inhibition of the p38 mitogen-activated protein kinase/nuclear factor-κB pathway.
Yu X; Cui L; Hou F; Liu X; Wang Y; Wen Y; Chi C; Li C; Liu R; Yin C
Int J Mol Med; 2018 Jan; 41(1):409-420. PubMed ID: 29138810
[TBL] [Abstract][Full Text] [Related]
9. Involvement of p38 MAPK activation mediated through AT1 receptors on spinal astrocytes and neurons in angiotensin II- and III-induced nociceptive behavior in mice.
Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
Neuropharmacology; 2015 Dec; 99():221-31. PubMed ID: 26209257
[TBL] [Abstract][Full Text] [Related]
10. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Su Z; Zimpelmann J; Burns KD
Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
[TBL] [Abstract][Full Text] [Related]
12. The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos.
Wang L; Liang J; Leung PS
PLoS One; 2015; 10(6):e0128216. PubMed ID: 26029927
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytochrome P450c17 reduces spinal astrocyte activation in a mouse model of neuropathic pain via regulation of p38 MAPK phosphorylation.
Choi SR; Beitz AJ; Lee JH
Biomed Pharmacother; 2019 Oct; 118():109299. PubMed ID: 31387001
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells.
Nie W; Yan H; Li S; Zhang Y; Yu F; Zhu W; Fan F; Zhu J
Mol Immunol; 2009 Jan; 46(3):355-61. PubMed ID: 19041135
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
17. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain.
Tatsumi E; Yamanaka H; Kobayashi K; Yagi H; Sakagami M; Noguchi K
Glia; 2015 Feb; 63(2):216-28. PubMed ID: 25130721
[TBL] [Abstract][Full Text] [Related]
18. Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.
Ved N; Da Vitoria Lobo ME; Bestall SM; L Vidueira C; Beazley-Long N; Ballmer-Hofer K; Hirashima M; Bates DO; Donaldson LF; Hulse RP
J Physiol; 2018 Aug; 596(16):3675-3693. PubMed ID: 29774557
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
